NCT02761980View on ClinicalTrials.gov

A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers

PHASE3CompletedINTERVENTIONAL
Enrollment

290

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

December 6, 2017

Study Completion Date

December 6, 2017

Conditions
Fever
Interventions
DRUG

Ibuprofen 250 mg / Acetaminophen 500 mg

Ibuprofen 250 mg / Acetaminophen 500 mg

DRUG

Ibuprofen 250 mg

Ibuprofen 250 mg

DRUG

Acetaminophen 500 mg

1 APAP 500 mg caplet

DRUG

Placebo

Placebo tablet

Trial Locations (1)

37920

New Orleans Center for Clinical Research, Knoxville

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02761980 - A Study of Ibuprofen 250 mg / Acetaminophen 500 mg Comparing The Antipyretic Effects in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter